Moderna executives said on Analyst Day that the company expects to discuss the COVID-19 vaccine declaration with the US Food and Drug Administration in the near future.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.